Challenges in Achieving Adequate Vitamin D Status in the Adult Population/ Part 2
VITAD/2
1 other identifier
interventional
105
1 country
1
Brief Summary
The efficiency of different vitamin D formulations in treating suboptimal vitamin D status in adult population will be determined. It will provide insights into the influence of formulation on vitamin D absorption. A randomised controlled intervention trial will be conducted on at least 72 subjects (18-65 years) with suboptimal Vitamin D status. Subjects will be selected from a pool of subjects in Part 1 of the study, after completion of winter sampling. Study subjects will be randomised into four study groups (at least 18 subjects per study group). Three different treatments will be compared with a control group, which will not receive any supplemental Vitamin D. The three tested Vitamin D preparations in the treatment groups will be (A) oil-based VALENS vitamin D; (B) water-based VALENS vitamin D; and (C) Vitamin D capsules with starch-adsorbed vitamin D (powder). All these products are commercially available. Prior to study, actual level of vitamin D will be determined using appropriate analytical method. The treatment will be with 1000 IU Vitamin D per day, for two months, in all three groups. Second serum vitamin D level will be determined on last day of the treatment, and compared with pre-treatment vitamin D level.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2019
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 8, 2019
CompletedFirst Submitted
Initial submission to the registry
January 17, 2019
CompletedFirst Posted
Study publicly available on registry
January 18, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 2, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
April 2, 2019
CompletedJune 22, 2021
June 1, 2021
3 months
January 17, 2019
June 16, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Change in vitamin D serum concentration after 8 weeks of supplementation
8 weeks
Study Arms (4)
Oil-based vitamin D group
EXPERIMENTALOil-based vitamin D, 1000 IU/day for 8 weeks
Water-based vitamin D group
EXPERIMENTALWater-based vitamin D, 1000 IU/day for 8 weeks
Vitamin D capsules group
EXPERIMENTALVitamin D capsules with starch-adsorbed vitamin D (powder), 1000 IU/day for 8 weeks
Control group
NO INTERVENTIONThis group will receive no intervention.
Interventions
Participants will receive oil-based VALENS vitamin D, 1000 IU/day for 8 weeks.
Participants will receive water-based VALENS vitamin D, 1000 IU/day for 8 weeks.
Participants will receive vitamin D capsules with starch-adsorbed vitamin D (powder), 1000 IU/day for 8 weeks.
Eligibility Criteria
You may qualify if:
- vitamin D suboptimal status
- Signed Informed consent form (ICF),
- Caucasian race
- Age between 18 and 65 years at the time of the signature of Informed consent form (ICF),
- Willingness to avoid a consumption of any food supplements containing Vitamin D during the study, except the ones prescribed by the study researchers, and to avoid use of solarium or other artificial UVB sources
- Willingness to follow all study procedures
You may not qualify if:
- Pregnancy or breastfeeding,
- Known or suspected allergy to any ingredient of the tested products in Part 2,
- Pronounced avoidance of sunshine (eg reporting of allergy to the sun)
- Special dietary habits used by a small part of the population (veganism, low-carb high-fat (LCHF) diet, caloric restriction diet, note: vegetarians are not excluded)
- Diets prescribed by the medical profession
- Disorders of the kidneys, thyroid, digestive tract, osteoporosis and other bone diseases, skin diseases
- Other diseases and conditions that affect the absorption and synthesis of vitamin D
- Exposure to stronger sunlight in the last three months prior to engaging in a survey (travel to countries with stronger sunshine, use of solarium),
- The consumption of margarine or plant substitutes for milk / milk products several times a day, as these foods are most often enriched with vitamin D,
- Visiting the solarium in the last three months before joining the survey,
- Mental incapacity that precludes adequate understanding or cooperation.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Institute of Nutrition, Slovenia (Nutris)lead
- VIST - Faculty of Applied Sciencescollaborator
- Slovenian Research Agencycollaborator
- Valens Int. d.o.o., Slovenijacollaborator
Study Sites (1)
Nutrition Institute, Ljubljana
Ljubljana, 1000, Slovenia
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Katja Žmitek, PhD
Researcher
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 17, 2019
First Posted
January 18, 2019
Study Start
January 8, 2019
Primary Completion
April 2, 2019
Study Completion
April 2, 2019
Last Updated
June 22, 2021
Record last verified: 2021-06
Data Sharing
- IPD Sharing
- Will not share